Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy for obsessive-compulsive disorder.

E Hollander1, A Kaplan, A Allen

  • 1Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA. eric.hollander@mssm.edu

The Psychiatric Clinics of North America
|September 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using electrical impedance tomography to estimate tidal volume in bottlenose dolphins and cape fur seals in seawater and on land.

The Journal of experimental biology·2026
Same author

Loss of tight junction protein claudin 18 uncovers alveolar epithelial stem cell plasticity and emergence of non-fibrogenic transitional progenitors.

bioRxiv : the preprint server for biology·2025
Same author

Effect on compression of lowering the design adiabat in the SQ-n campaign.

Physical review. E·2025
Same author

First Demonstration of Improved Fusion Yield with Increased Compression through Reduced Adiabat in Inertial Confinement Fusion Experiments at the National Ignition Facility.

Physical review letters·2025
Same author

Early adaptive schemas, emotional regulation, and cognitive flexibility in eating disorders: subtype specific predictors of eating disorder symptoms using hierarchical linear regression.

Eating and weight disorders : EWD·2024
Same author

Design of the first fusion experiment to achieve target energy gain G>1.

Physical review. E·2024

Selective serotonin reuptake inhibitors (SSRIs) and clomipramine are common treatments for obsessive-compulsive disorder (OCD). However, many patients do not respond to these serotonin reuptake inhibitors (SRIs), necessitating alternative pharmacological strategies.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Selective serotonin reuptake inhibitors (SSRIs) and clomipramine are primary treatments for obsessive-compulsive disorder (OCD).
  • SSRIs offer a more favorable side-effect profile compared to clomipramine.
  • A significant portion of OCD patients (40-60%) exhibit inadequate response to standard serotonin reuptake inhibitor (SRI) therapies.

Purpose of the Study:

  • To explore alternative pharmacological treatments for OCD beyond first-line SRIs.
  • To investigate the efficacy of various augmentation and monotherapy strategies in treatment-resistant OCD cases.

Main Methods:

  • Review of existing literature on pharmacologic approaches for OCD.
  • Analysis of studies investigating augmentation and monotherapy with different drug classes.

Related Experiment Videos

Main Results:

  • Non-response to SRIs affects a substantial number of OCD patients.
  • Alternative agents including serotonergic enhancers, dopamine and 5-HT antagonists, second-messenger system enhancers, and GABAergic agents have been explored.
  • These alternative strategies show varying degrees of efficacy in managing OCD.

Conclusions:

  • Given the limitations of SSRIs and clomipramine, further research into alternative OCD pharmacotherapies is warranted.
  • Augmentation and monotherapy with diverse agents represent potential avenues for improving treatment outcomes in non-responsive OCD patients.